+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tissue Diagnostic Global Market Report 2022

  • PDF Icon

    Report

  • 175 Pages
  • August 2022
  • Region: Global
  • The Business Research Company
  • ID: 5640998
Major players in the tissue diagnostic market are Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Hologic, Qiagen, Bio Rad, BD, Genemed Biotechnologies Inc, Siemens, Merck KGaA, Cell Signaling Technology Inc and Cellpath Ltd.

The global tissue diagnostic market is expected to grow from $4.27 billion in 2021 to $4.56 billion in 2022 at a compound annual growth rate (CAGR) of 6.84%. The tissue diagnostic market is expected to grow to $5.99 billion in 2026 at a compound annual growth rate (CAGR) of 7.05%.

The tissue diagnostic market consists of sales of tissue diagnostics devices by entities (organizations, sole traders, and partnerships) that refer to a medical procedure that uses instruments to remove and stain tissue that must be sent to a laboratory or pathology department for documentation of what was excised for patient care (for tissue diagnostics). This offers measurements and descriptions including any abnormalities, and an interpretation (or diagnosis) of health or disease status, under applicable legislation.

The main types of product in tissue diagnostic are consumables, antibodies, kits, reagents, probes, instrument, slide staining system, scanner and tissue processing system. The antibodies are used for the detection of infections, recognition of allergies, and the measurement of hormones and other biological markers in the blood in tissue diagnostics. The technologies used in tissue diagnostic are immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and workflow management and special staining to detect diseases such as breast cancer, gastric cancer, lymphoma, prostate cancer and non-small cell lung cancer (NSCLC). Tissue diagnostic is mostly used in hospitals, research laboratories, pharmaceutical companies and contract research organizations.

North America was the largest region in the tissue diagnostic market in 2021. The regions covered in the tissue diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The tissue diagnostic market research report is one of a series of new reports that provides tissue diagnostic market statistics, including tissue diagnostic industry global market size, regional shares, competitors with a tissue diagnostic market share, detailed tissue diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the tissue diagnostic industry. This tissue diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rising incidence of cancer will propel the growth of the tissue diagnostics market during the forecast period. Cancer begins when genetic changes interfere, and cells start to grow uncontrollably and destroy body tissue and form a mass called a tumor. A tumor can be cancerous or benign. Cancer can be caused due to various reasons such as genetic mutations, cancer-causing chemicals (carcinogens), smoking, obesity, radiation, hormones and others. As the instances of occurring cancer increase, there will be a significant need for diagnostic procedures such as tissue diagnostics help in determining the disease state. For instance, according to the US voluntary health organization dedicated to eliminating cancer, the American Cancer Society, in the USA, there was an expected 1.8 million new cancer cases identified and 606,520 cancer deaths in 2020, and the number was expected to increase to 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in 2021. Therefore, the rising incidence of cancer drives the tissue diagnostics market.

Technological advancement is a key trend gaining popularity in the tissue diagnostics market. Technological advancements include the introduction of automated tissue diagnostic devices/machines that collect multiple sample types, test multiple samples simultaneously, automate lab operations, and make it accessible to everyone. Key players are focused on developing and offering these automated tissue diagnostic systems to gain a competitive edge in the market and increase revenue. For instance, in July 2020, Mylab Discovery Solutions, an Indian molecular diagnostics company introduced Compact XL - Lab in a Box, India’s first fully automated Sample-to-PCR-ready system for molecular diagnostics. The new system automates lab operations from sample handling to RT-PCR ready tube preparation and does these operations in one single compact benchtop system. The system can collect various types of samples such as tissue, plasma, swab, and sputum.

In February 2022, Labcorp, a US-based global life sciences company acquired Personal Genome Diagnostics (PGDx) for an amount of $575 million. With the addition of PGDx and its technology, Labcorp will expand its next-generation sequencing-based genomic profiling capabilities and strengthens the existing liquid biopsy capabilities. Personal Genome Diagnostics (PGDx) is an US-based company offering cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products.

The countries covered in the tissue diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.




This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary2. Tissue Diagnostic Market Characteristics3. Tissue Diagnostic Market Trends And Strategies4. Impact Of COVID-19 On Tissue Diagnostic
5. Tissue Diagnostic Market Size And Growth
5.1. Global Tissue Diagnostic Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Tissue Diagnostic Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Tissue Diagnostic Market Segmentation
6.1. Global Tissue Diagnostic Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Consumables
  • Antibodies
  • Kits
  • Reagents
  • Probes
  • Instruments
  • Slide Staining System
  • Scanner
  • Tissue Processing system
6.2. Global Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Immunohistochemistry (IHC)
  • In Situ Hybridization (ISH)
  • Digital Pathology And Workflow Management
  • Special Staining
6.3. Global Tissue Diagnostic Market, Segmentation By Disease, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-Small Cell Lung Cancer (NSCLC)
6.4. Global Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals
  • Research Laboratories
  • Pharmaceutical Companies
  • Contract Research Organizations
7. Tissue Diagnostic Market Regional And Country Analysis
7.1. Global Tissue Diagnostic Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Tissue Diagnostic Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Tissue Diagnostic Market
8.1. Asia-Pacific Tissue Diagnostic Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Tissue Diagnostic Market
9.1. China Tissue Diagnostic Market Overview
9.2. China Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Tissue Diagnostic Market
10.1. India Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Tissue Diagnostic Market
11.1. Japan Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Tissue Diagnostic Market
12.1. Australia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Tissue Diagnostic Market
13.1. Indonesia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Tissue Diagnostic Market
14.1. South Korea Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Tissue Diagnostic Market
15.1. Western Europe Tissue Diagnostic Market Overview
15.2. Western Europe Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Tissue Diagnostic Market
16.1. UK Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Tissue Diagnostic Market
17.1. Germany Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Tissue Diagnostic Market
18.1. France Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.2. France Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Tissue Diagnostic Market
19.1. Eastern Europe Tissue Diagnostic Market Overview
19.2. Eastern Europe Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Tissue Diagnostic Market
20.1. Russia Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Tissue Diagnostic Market
21.1. North America Tissue Diagnostic Market Overview
21.2. North America Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Tissue Diagnostic Market
22.1. USA Tissue Diagnostic Market Overview
22.2. USA Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Tissue Diagnostic Market
23.1. South America Tissue Diagnostic Market Overview
23.2. South America Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Tissue Diagnostic Market
24.1. Brazil Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Tissue Diagnostic Market
25.1. Middle East Tissue Diagnostic Market Overview
25.2. Middle East Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Tissue Diagnostic Market
26.1. Africa Tissue Diagnostic Market Overview
26.2. Africa Tissue Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Tissue Diagnostic Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Tissue Diagnostic Market Competitive Landscape And Company Profiles
27.1. Tissue Diagnostic Market Competitive Landscape
27.2. Tissue Diagnostic Market Company Profiles
27.2.1. Roche
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Danaher
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Thermo Fisher Scientific
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Abbott
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Agilent Technologies
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Tissue Diagnostic Market29. Tissue Diagnostic Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright And Disclaimer

Executive Summary

Tissue Diagnostic Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global tissue diagnostic market.

This report focuses on tissue diagnostic market which is experiencing strong growth. The report gives a guide to the tissue diagnostic market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for the tissue diagnostic? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Tissue Diagnostic market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider tissue diagnostic market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The tissue diagnostic market section of the report gives context. It compares the tissue diagnostic market with other segments of the tissue diagnostic market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, tissue diagnostic indicators comparison.

Scope


Markets Covered:

1) By Product: Consumables; Antibodies; Kits; Reagents; Probes; Instruments; Slide Staining System; Scanner; Tissue Processing system
2) By Technology: Immunohistochemistry (IHC); In Situ Hybridization (ISH); Digital Pathology And Workflow Management; Special Staining
3) By Disease: Breast Cancer; Gastric Cancer; Lymphoma; Prostate Cancer; Non-Small Cell Lung Cancer (NSCLC)
4) By End User: Hospitals; Research Laboratories; Pharmaceutical Companies; Contract Research Organizations

Companies Mentioned: Roche; Danaher; Thermo Fisher Scientific; Abbott; Agilent Technologies

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Roche
  • Danaher
  • Thermo Fisher Scientific
  • Abbott
  • Agilent Technologies

Methodology

Loading
LOADING...